In contrast, BTLA exhibited a significantly reduced expression in TILs compared to PBMCs (PBMCs: 32.4%; TILs: 22.6%), suggesting a distinct pattern of regulatory receptor modulation within the tumor microenvironment. The gene discussed is BTLA; the disease is neoplasm.